LGH-447

N/A

Report date: 2025/11/10 20:01:49
NME

Base Information

Drug NameLGH-447
Drug Alias NameLGH-447PIM-447
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProto-oncogene serine/threonine-protein kinase Pim-1 inhibitors
TargetsProto-oncogene serine/threonine-protein kinase Pim-1
Therapy Area/IndicationsPrimary MyelofibrosisMultiple MyelomaLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[11] 
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsPrimary MyelofibrosisMultiple MyelomaLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A